Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Standards of Care II

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:

Standards of Care I

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Health care variation: the next challenge for clinical colleges.

The Medical journal of Australia·2017

Same author

Health care variation: time to act.

The Medical journal of Australia·2016

Same author

Variation in coronary angiography rates in Australia: correlations with socio-demographic, health service and disease burden indices.

The Medical journal of Australia·2016

Same author

Australian health policy makers' priorities for research synthesis: a survey.

Australian health review : a publication of the Australian Hospital Association·2012

Same author

From the Australian Commission on Safety and Quality in Health Care. Assessment of competence in communication of risk.

The Medical journal of Australia·2012

Same author

Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence.

The Medical journal of Australia·2009

Search research articles

Related Experiment Videos

Australian clinical practice guidelines--a national study.

Heather A Buchan¹, Kay C Currie, Emma J Lourey

¹National Institute of Clinical Studies, National Health and Medical Research Council, Melbourne, VIC, Australia.

The Medical Journal of Australia

|May 5, 2010

Summary

This summary is machine-generated.

Australian clinical practice guidelines (CPGs) show a need for better coordination and transparency. While 313 CPGs were identified, only 29% were evidence-documented, with many lacking conflict of interest disclosures.

Related Experiment Videos

Area of Science:

Health Services Research
Evidence-Based Medicine
Public Health Policy

Background:

Clinical practice guidelines (CPGs) are crucial for evidence-based healthcare delivery.
The development and characteristics of Australian CPGs require systematic evaluation to ensure quality and relevance.
Understanding the landscape of CPG production is essential for optimizing healthcare investments.

Purpose of the Study:

To quantify the number of Australian clinical practice guidelines produced or reviewed between 2003 and 2007.
To characterize key features of these guidelines, including evidence documentation and development processes.

Main Methods:

A comprehensive search of health organizations and websites identified national and state-level CPGs in Australia.
Data on guideline characteristics were abstracted from published documents and accompanying materials.
Key metrics included the number of guidelines, health areas covered, evidence appraisal, producer/funder information, and competing interest statements.

Main Results:

A total of 313 Australian CPGs were identified, with only 91 (29%) being evidence-documented.
Government agencies were involved in 53% of guidelines, but only 28% of these were evidence-documented.
Many guidelines lacked specified review dates or mentioned competing interests (79%).

Conclusions:

A coordinated national strategy is needed to prioritize the development and updating of CPGs for better investment returns.
Increased transparency in the guideline development process, particularly regarding competing interests, is essential.
Addressing these gaps can enhance the quality and impact of Australian clinical practice guidelines.